Factors affecting radiographic marginal bone resorption at dental implants in function for at least 5 years: A multicenter retrospective study
Clinical Oral Implants Research · 2024-11 · 35 (11) · 1406-1417
DOI: 10.1111/clr.14327 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Oral Implants Research, online erschienen am 15.07.2024. Verfasst von Leonardo Trombelli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for the Study of Periodontal and Peri-Implant Diseases, University of Ferrara, Ferrara, Italy. Hauptthemen laut MEDLINE: Dental Implants, Alveolar Bone Loss. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To evaluate the influence of patient and implant‐related factors on the changes of marginal bone levels (MBL) at implants with a follow‐up ≥5 years. Materials and Methods At baseline (within 6 months from prosthetic insertion) and long‐term (≥5 years after implant placement) visits, interproximal (mesial and distal) MBL were radiographically evaluated. To analyze factors predicting MBL change, the site (either mesial or distal) showing the highest MBL change (hChMBL site) was identified for each implant. Multilevel regression models were built to explain MBL change as well as the probability for a bone loss ≥2 mm at long‐term.
Results
942 implants in 312 patients with a mean follow‐up of 8.02 ± 2.5 years were analyzed. MBL change was significantly predicted by baseline MBL, oral bisphosphonate (BP) intake, history of periodontitis, diabetes, and super‐hydrophilic implant surface. Higher risk for a bone loss ≥2 mm was observed in patients with history of periodontitis (OR = 9.52, 95% CI 0.72–3.79) and taking BP (OR = 6.84, 95% CI 0.21–3.63). Mandibular implants had higher odds for bone loss ≥2 mm compared to maxillary implants (OR = 3, 95% CI 0.39–1.87).
Conclusions
The findings of the present study contribute to the identification of specific clinical scenarios at higher risk for implant‐supporting bone loss that need to be strictly monitored during maintenance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Centre for the Study of Periodontal and Peri-Implant Diseases, University of Ferrara, Ferrara, Italy.
- Operative Unit of Dentistry, AUSL of Ferrara, Ferrara, Italy.
- Department of Periodontology, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
- Section of Periodontology, Faculty of Odontology, University Complutense of Madrid, Madrid, Spain.
- Private Practice in Napoli, Napoli, Italy.
- Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi, Italy.
ORCID-Profile: Roberto Farina, Cristiano Tomasi, Fabio Vignoletti, Anna Simonelli
Zitieren
APA
Trombelli, L., Farina, R., Tomasi, C., Vignoletti, F., Paolantoni, G., Giordano, F., Ortensi, L., & Simonelli, A. (2024). Factors affecting radiographic marginal bone resorption at dental implants in function for at least 5 years: A multicenter retrospective study. Clinical Oral Implants Research, 35(11), 1406-1417. https://doi.org/10.1111/clr.14327
Vancouver
Trombelli L, Farina R, Tomasi C, Vignoletti F, Paolantoni G, Giordano F, et al. Factors affecting radiographic marginal bone resorption at dental implants in function for at least 5 years: A multicenter retrospective study. Clinical Oral Implants Research. 2024;35(11):1406-1417. doi:10.1111/clr.14327
BibTeX
@article{Trombelli2024,
author = {Trombelli, Leonardo and Farina, Roberto and Tomasi, Cristiano and Vignoletti, Fabio and Paolantoni, Guerino and Giordano, Francesco and Ortensi, Luca and Simonelli, Anna},
title = {Factors affecting radiographic marginal bone resorption at dental implants in function for at least 5 years: A multicenter retrospective study},
journal = {Clinical Oral Implants Research},
year = {2024},
volume = {35},
number = {11},
pages = {1406--1417},
doi = {10.1111/clr.14327}
}
EUVIMED